Cases of cutaneous anthrax in eastern Turkey: The reports of three cases

Sevdegül KARADAŞ, Hayriye GÖNÜLLÜ, Mehmet Reşat CEYLAN, Fatih ESMER, Senar EBİNÇ
1.597 255


Anthrax is an acute disease caused by the bacterium Bacillus anthracis. This bacteria can form dormant endospores. When spores are inhaled, ingested, or come into contact with a skin lesion on a host, they may become reactivated multiply and rapidly. B. anthracis bacterial spores are soil-borne. Because of their long lifespan, spores are present globally and remain at the burial sites of animals killed by anthrax for many decades. Diseased animals can spread anthrax to humans, either by direct contact or by consumption of a diseased animal’s flesh. The most frequent clinical type of anthrax is cutaneous anthrax. It presents as a boil-like skin lesion that eventually forms an ulcer with a black center (eschar). Cutaneous anthrax form often within the site of spore penetration between two and five days after exposure. Until the 20th century, anthrax infections killed thousands of animals and people worldwide each year. Animal vaccination programs and antibiotic therapy were decreased the number of deaths. But, anthrax is still a problem in less developed countries. It has been reported that the incidence of disease has decreased in Turkey. However, we present here in three cases of cutaneous anthrax admitted to the emergency department of our hospital within a week.


Cutaneous anthrax; Emergency department; Frequency; Zoonotic disease

Full Text:



Akdeniz, N., Calka, O., Ozkol, H.U., Akdeniz, H., 2013. Cutaneous anthrax resulting in renal failure with generalized tissue damage. Cutan. Ocul. Toxicol. 32, 327-329. doi: 10.3109/15569527.2013.768257.

Baykam, N., Ergonul, O., Ulu, A., Eren, S., Celikbas, A., Eroglu, M., Dokuzoguz, B., 2009. Characteristics of cutaneous anthrax in Turkey. J. Infect. Dev. Ctries. 15, 599-603. doi:10.3855/jidc.551.

Devrim, I., Kara, A., Tezer, H., Cengiz, A.B., Ceyhan, M., Seçmeer, G., 2009. Animal carcass and eyelid anthrax: A case report. Turk J. Pediatr. 51, 67-68.

Doganay, M., Metan, G., Alp, E., 2010. A review of cutaneous anthrax and its outcome. J. Infect. Public Health. 3, 98-105. doi: 10.1016/j. jiph.2010.07.004

Freedberg, I.M., Eisen, A.Z., Wolff, K., Austen, K.F., Goldsmith, L.A., Katz, S.I., 2003. Anthrax. In: Fitzpatrick’s dermatology in general medicine. 6th ed. McGraw-Hill, pp, 1919-1921.

Kayabas, U., Karahocagil., M.K., Ozkurt, Z., Metan, G., Parlak, E., Bayindir, Y., Kalkan, A., Akdeniz, H., Parlak, M., Simpson, A.J., Doganay, M., 2012. Naturally occurring Cutaneous Anthrax: Antibiotic treatment and outcome. Chemotherapy. 58, 34-43. doi: 10.1159/000335593.

Lucey, D., 2005. Bacillus anthracis (Anthrax). In: Mandell, G.L., Bennett, J.E., Dolin, R., editors. Principles and practice of infectious diseases. Philadelphia: Elsevier-Churchill Livingstone, pp, 2485-2493.

Meric, M., Willke, A., Muezzinoglu, B., Karadenizli, A., Hosten, T., 2009. A case of pneumonia caused by Bacillus anthracis secondary to gastrointestinal anthrax. Int. J. Infect. Dis. 13, 456-458. doi: 10.1016/j.ijid.2008.12.008.

Ozcan, H., Kayabas, U., Bayindir, Y., Bayraktar, M.R., Ay, S., 2008. Evaluation of 23 cutaneous anthrax patients in eastern Anatolia,Turkey: Diagnosis and risk factors. Int. J. Dermatol. 47, 1033-1037. doi: 10.1111/j.1365-4632.2008.03665.x.

Sirisanthana, T., Brown, A.E., 2002. Anthrax of the gastrointestinal tract. Emerg. Infect. Dis. 8, 649-651. doi: 10.3201/eid0807.020062.